Estadística i Investigació Operativa
Departament
University of California, San Francisco
San Francisco, Estados UnidosPublicacions en col·laboració amb investigadors/es de University of California, San Francisco (4)
2022
-
Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature
International Journal of Cancer, Vol. 150, Núm. 12, pp. 2072-2082
2021
-
Assessment of 25-Year Survival of Women with Estrogen Receptor-Positive/ ERBB2 -Negative Breast Cancer Treated with and without Tamoxifen Therapy: A Secondary Analysis of Data from the Stockholm Tamoxifen Randomized Clinical Trial
JAMA Network Open, Vol. 4, Núm. 6
-
Characterization of Benign Breast Diseases and Association with Age, Hormonal Factors, and Family History of Breast Cancer among Women in Sweden
JAMA Network Open, Vol. 4, Núm. 6
2019
-
Assessment of Long-term Distant Recurrence-Free Survival Associated with Tamoxifen Therapy in Postmenopausal Patients with Luminal A or Luminal B Breast Cancer
JAMA Oncology, Vol. 5, Núm. 9, pp. 1304-1309